QT Prolongation Trial For All Drugs Recommended By ICH Draft Guidance

All drugs should undergo a single cardiac QT interval prolongation trial early in development, an International Conference on Harmonization draft guidance on clinical evaluation of QT prolongation, released Sept. 13, states